2017
DOI: 10.3389/conf.fnins.2017.94.00057
|View full text |Cite
|
Sign up to set email alerts
|

The phospholipase A2 signaling as a new therapeutic biomarker of Alzheimer’s disease: modulation through phage display-derived peptides able to cross the blood-brain barrier

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles